ARCH Venture Partners X, L.P.
CIK 1782583 · last filed 2021-06-23
ARCH Venture Partners X, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for VERV, was dated Jun 23, 2021. Current disclosed insider exposure totals $33.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$33.08M
2
2
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 1,254,404 | $11.13 | $13.96M | $0 | 1 | 2021-06-23 |
| SANA | 10%+ Owner | 10,303,750 | $3.21 | $33.08M | $0 | 1 | 2021-02-10 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-23 | Verve Therapeutics, Inc. (VERV) Delisted | Conv (C) | +22,579,281 | $0 | EDGAR |
| 2021-02-10 | SANA | Conv (C) | +437,500,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.